ArticlePreventive medicine reports2015
Adherence to cervical cancer screening varies by human papillomavirus vaccination status in a high-risk population.
Article in Preventive medicine reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 4 syntheses or guidelines pooled it, 26 citations in OpenAlex.
- Association of human papillomavirus vaccination with cervical cancer screening: A systematic review and meta-analysis.Medicine · 2022Pooled it
- Patient Adherence to Screening for Lung Cancer in the US: A Systematic Review and Meta-analysis.JAMA network open · 2020Pooled it
- Benefits and harms of the human papillomavirus (HPV) vaccines: systematic review with meta-analyses of trial data from clinical study reports.Systematic reviews · 2020Pooled it
- Identifying the key barriers, facilitators and factors associated with cervical cancer screening attendance in young women: A systematic review.Women's health (London, England)Pooled it
- Social factors and age play a significant role in cervical cancer and advanced-stage disease among Danish women.BMC cancer · 2024Article
- Non-use and inadequate use of cervical cancer screening among a representative sample of women in the United States.Frontiers in public health · 2024Article
- Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013-2019.Gynecologic oncology · 2021Article
- Use of cervical cancer preventive services among US women aged 21-29: an assessment of the 2010 Affordable Care Act rollout through 2018.Cancer causes & control : CCC · 2020Article
- Non-Adherence To Childhood HPV Vaccination Is Associated With Non-Participation In Cervical Cancer ScreeningClinical epidemiology · 2019Article
- Opportunistic HPV vaccination at age 16-23 and cervical screening attendance in Sweden: a national register-based cohort study.BMJ open · 2018Article
- Impact of HPV vaccination on outcome of cervical cytology screening in Denmark-A register-based cohort study.International journal of cancer · 2018Article
- Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.Journal of women's health (2002) · 2017Article
- Article
- Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.American journal of obstetrics and gynecology · 2017Article
- HPV immunisation and increased uptake of cervical screening in Scottish women; observational study of routinely collected national data.British journal of cancer · 2016Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 10 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer screening has reduced the incidence of cervical cancer over the past 75 years. The primary aim of this study was to determine if women receiving Gardasil™ (HPV4 vaccine) participated in future cervical cancer screening at the same rate as that observed for unvaccinated women matched on birth year and health care campus. This is a retrospective cohort study of subjects selected from 27,786 females born from 1980 to 1992 who received health care in the Truman Medical Center safety net health system in Kansas City Missouri, USA. 1154 women 14-26 years old who received at least one dose of HPV4 vaccine between 2006 and 2009 were chosen at random from the vaccine records. 1154 randomly chosen unvaccinated women were age and health campus matched to the vaccinated women and all were followed until July 1, 2013. Women who were screened after 21 years and received three vaccine doses before 21 years, had the lowest screening rate of 24%. Their only predictive factor for screening, compared to the unvaccinated, was being closer to 21 years than 14 years at vaccination (aOR = 1.71 95% CI: 1.45, 2.00). Women vaccinated with three doses and screened at or after 21 years had the highest screening rate of 84% predicting a six-fold increase in screening participation over no vaccine received (aOR = 5.94 95% CI: 3.77, 9.35). Our results suggest that women who receive HPV4 vaccination closer to 21 years, not 14, are more likely to participate in cervical cancer screening in an underserved US population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.